Minaris Regenerative Medicine GmbH (früher apceth Biopharma GmbH)

Biotechnology, Medical Technology

  • Short facts

  • Year founded 2007
  • 137 Employees (site)
  • Turnover: not available

Products/services: Creating Cell Therapy Miracles Together Minaris Regenerative Medicine is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics. The company has a comprehensive expertise in GMP manufacturing of autologous and allogeneic cell types that are either native or genetically modified. It has long-standing experience with various cell products, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSC), lymphocytes, monocytes, dendritic cells, cord blood derived stem cells, and has the potential to expand to CAR-T and induced pluripotent stem cell (iPSC) technologies. apceth has successfully obtained manufacturing licenses for multiple cell therapy products for clinical as well as commercial use. Creating Cell Therapy Miracles Together Minaris Regenerative Medicine is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics. The company has a comprehensive expertise in GMP manufacturing of autologous and allogeneic cell types that are either native or genetically modified. It has long-standing experience with various cell products, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSC), lymphocytes, monocytes, dendritic cells, cord blood derived stem cells, and has the potential to expand to CAR-T and… read more 

Basic data

Company

Minaris Regenerative Medicine GmbH (früher apceth Biopharma GmbH)

Street

Haidgraben 5

PC / City

85521 Ottobrunn

County

Upper Bavaria

Phone

+49 89 7009608-0

Fax

+49 89 7009608-130

Language skills

English, German

Contact person

Sales / marketing: Dr. Almut Windhager (Mrs.)
Management: Dusan Kosijer (Mr.)

Profile/competences

Core competencies

CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION (CDMO)
•Reliable, experienced and high-performance partner for our clients
•Complex cell-based and gene therapy products (ATMPs)
•Pioneer in the development of cell-based gene therapies
•Clinical and commercial GMP manufacturing
•Process, product and assay development
•GMP-certified since 2010

Key sectors / sub-sectors

  • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
  • Biotechnology: Tissue engineering and regenerative medicine
  • Medical Technology: Implants, biomaterials, tissue engineering

NACE industries

  • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
  • Manufacture of pharmaceutical preparations 21.2
  • Manufacture of pharmaceutical preparations 21.20
  • Scientific research and development 72
  • Research and experimental development on natural sciences and engineering 72.1
  • Research and experimental development on biotechnology 72.11

Certifications

not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available